9JAL
Cryo-EM structure of MPXV core protease in complex with compound A1
This is a non-PDB format compatible entry.
Summary for 9JAL
| Entry DOI | 10.2210/pdb9jal/pdb |
| EMDB information | 61292 |
| Descriptor | Core protease I7, A1ECM-DI8-ALA-ETA (2 entities in total) |
| Functional Keywords | orthopoxviruses, mpox, protease, viral replication, drug discovery, inhibitor, viral protein |
| Biological source | Monkeypox virus More |
| Total number of polymer chains | 4 |
| Total formula weight | 99142.14 |
| Authors | |
| Primary citation | Gao, Y.,Xie, X.,Zhang, X.,Cao, J.,Lan, W.,You, T.,Li, D.,Dong, X.,Dai, W.,Xiang, Y.,Hu, S.,Shang, W.,Wu, B.,Zhang, Y.,Xu, J.,Liu, X.,Wang, H.,Hu, W.,Zhang, M.,Duan, Y.,Cui, W.,Zhou, H.,Mao, S.,Jia, H.,Sun, Z.,Jia, M.,Yin, Y.,Nguyen, H.C.,Yang, K.,Yang, B.,Yang, X.,Ji, X.,Xiao, G.,Wang, W.,Zhang, L.,Rao, Z.,Liu, H.,Yang, H. Substrate recognition and cleavage mechanism of the monkeypox virus core protease. Nature, 2025 Cited by PubMed Abstract: Poxviruses cause severe diseases, including smallpox and mpox, that pose major threats to human health. The poxvirus core protease (Core) is essential for viral maturation and is highly conserved in poxviruses, making it an attractive antiviral target. However, the structure of Core remains unknown, hampering antiviral development. Here we determined the apo structure of monkeypox virus (MPXV) Core and the structure of Core in a complex with the inhibitor aloxistatin, a drug candidate for muscular dystrophy. These structures show that Core forms a homodimer that features a unique 'dancing couple' fold. The catalytic intermediate state of Core was characterized by an aldehyde derivative from a natural substrate (I-G18). This derivative binds covalently to the catalytic Cys328, shifting the active site of the viral protease from a closed conformation in the apo form to a favourable open conformation upon substrate binding. On the basis of the Core-I-G18 complex, we designed a series of peptidomimetic inhibitors with a nitrile warhead, which could covalently anchor with the catalytic Cys328. These compounds inhibit Core with half-maximal inhibitory concentrations of 44.9-100.3 nM, and exhibit potent and broad anti-poxvirus activity. Our studies provide a basis for designing wide-spectrum inhibitors against poxvirus infections. PubMed: 40262633DOI: 10.1038/s41586-025-09014-x PDB entries with the same primary citation |
| Experimental method | ELECTRON MICROSCOPY (3.03 Å) |
Structure validation
Download full validation report
